Clear Filters KOL/Analyst Event February 19, 2024 KOL/Analyst Event Read More Varney & Co. 02/7/24 February 18, 2024 Varney & Co. 02/7/24 Read More Presentation: GT-02287, a clinical stage GCase enhancer, displays neuroprotection and restores motor function in preclinical models of Parkinson’s disease following delayed administration February 13, 2024 Presentation: GT-02287, a clinical stage GCase enhancer, displays neuroprotection and restores motor function in preclinical models of Parkinson’s disease following delayed administration Read More New Parkinson’s Treatment Progresses in Phase 1 Clinical Trial January 17, 2024 New Parkinson’s Treatment Progresses in Phase 1 Clinical Trial Read More Beyond Numbers: Unpacking the Rich History of the J.P. Morgan Healthcare Conference January 2, 2024 Beyond Numbers: Unpacking the Rich History of the J.P. Morgan Healthcare Conference Read More Nature Scientific Reports links glucocerebrosidase (GCase) dysfunction and neurodegenerative diseases November 11, 2023 Nature Scientific Reports links glucocerebrosidase (GCase) dysfunction and neurodegenerative diseases Read More Alpha Synuclein: Implications Beyond Parkinson’s Disease October 18, 2023 Alpha Synuclein: Implications Beyond Parkinson’s Disease Read More Gain Therapeutics: Developing New Medicines for Protein Misfolding Diseases September 21, 2023 Gain Therapeutics: Developing New Medicines for Protein Misfolding Diseases Read More The Critical Importance of Neurodegenerative Disease Biomarkers September 2, 2023 The Critical Importance of Neurodegenerative Disease Biomarkers Read More Corporate Presentation August 2024 Corporate Presentation Download
